Epidemiology and clinical features of community-onset acinetobacter baumannii infections

Infection Control and Hospital Epidemiology

Volumn 33, Issue 10, 2012, Pages 1053-1055

  Kang, Seung Ji ^a,b   Kang, Cheol In ^a   Park, So Yeon ^a   Ha, Young Eun ^a   Joo, Eun Jeong ^a   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Lee, Nam Yong ^a   Song, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CEFTAZIDIME; CEPHALOSPORIN; GENTAMICIN; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE;

ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL FEATURE; ENTEROBACTERIACEAE; FEMALE; HUMAN; INFECTION RISK; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; REPUBLIC OF KOREA;

EID: 84866148043     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/667739     Document Type: Letter

References (9)

1. Kang CI, Chung DR, Peck KR, Song JH. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED. Am J Emerg Med 2011, doi:10.1016/j.ajem.2011.08.021.
2. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791-797.
3. Kwon KT, Oh WS, Song JH, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007;59:525-530.
4. Joung MK, Kwon KT, Kang CI, et al. Impact of inappropriate antimicrobial therapy on outcome in patients with hospitalacquired pneumonia caused by Acinetobacter baumannii. J Infect 2010;61:212-218.
5. Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. Communityacquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis 2007;26:857-868.
6. Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008;46:1121-1122.
7. Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect 2009;73:143-150.
8. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005;11:868-873.
9. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46:1254-1263.